Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/2859
Title: | Hydroxyurea and nonmelanoma skin cancers: Report on three cases and review of the literature | Authors: | Roš, Tatjana Gajić, Branislava Gajinov, Zorica Ivkov Simić, Milana Stojanović , Marko Golušin, Zoran |
Issue Date: | 1-Nov-2017 | Journal: | Vojnosanitetski Pregled | Abstract: | © 2017, Institut za Vojnomedicinske Naucne Informacije/Documentaciju. All rights reserved. Introduction. Hydroxyurea (HU) is a cytostatic agent, frequently used for the treatment of myeloproliferative disorders, sickle cell anemia and severe forms of psoriasis. Cutaneous side effects occur in up to one third of patients taking hydroxyurea, with the most serious side effect being susceptibility to develop non-melanoma skin cancers. Case report. We report 3 patients using HU that have developed multiple skin malignancies on the head and neck region and dorsa of the hands, arranged according to the level of the overall squamous dysplasia expressed. Conclusion. A cumulative dose of hydroxyurea affects skin cancer promotion in concordance with other risk factors determining cumulative ultraviolet exposure (age of the patients, skin phototype, sun habits), but the exact influence of each of them and enrollment of other possible cofactors remains to be elucidated. We point out the importance of adequate skin cancer preventive and therapeutic approach to the patients treated with hydroxyurea. | URI: | https://open.uns.ac.rs/handle/123456789/2859 | ISSN: | 428450 | DOI: | 10.2298/VSP160218298R |
Appears in Collections: | MDF Publikacije/Publications |
Show full item record
SCOPUSTM
Citations
1
checked on May 3, 2024
Page view(s)
46
Last Week
14
14
Last month
8
8
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.